Stifel Financial’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Stifel Financial’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-341,000	Closed	-$1.7M	–	2446
2015 Q3	$1.7M	Sell	341,000 -341,285	-50%	-$1.83M	0.01%	992
2015 Q2	$12.4M	Hold	682,285	–	–	0.06%	314
2015 Q1	$19.7M	Buy	682,285 +351,023	+106%	+$3.62M	0.11%	229
2014 Q4	$12.6M	Hold	331,262	–	–	0.07%	341
2014 Q3	$5.16M	Hold	331,262	–	–	0.05%	461
2014 Q2	$5.16M	Buy	+331,262	New	+$5.03M	0.05%	451

Other funds holding TRIV

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial's TRIV Position: Q4 2015 in Review

Stifel Financial sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q4 2015, closing a stake of 341,000 shares — an estimated $1.7M sold.

Stifel Financial first reported a position in TRIV in Q2 2014 and held it in 6 quarters. The position peaked at $19.7M in Q1 2015. 25 funds tracked by Wall St. Rank hold TRIV as of Q4 2015.

Stifel Financial reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q4 2015 after selling out during the quarter.
Stifel Financial sold 341,000 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q4 2015, an estimated $1.7M.
Stifel Financial first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 6 quarters.
Stifel Financial's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $19.7M in Q1 2015.
25 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q4 2015.

Based on Stifel Financial's 13F filing for Q4 2015, filed 16 Feb 2016.